Management of Hepatitis with Indigenous drugs
Phase 2
- Conditions
- Health Condition 1: K701- Alcoholic hepatitis
- Registration Number
- CTRI/2024/05/067339
- Lead Sponsor
- Dr Soumya Sucharita Sarangi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Drug induced hepatitis
Hepatitis A & E
Alcohol induced hepatitis
Exclusion Criteria
Hepatitis with other metabolic disorders
Lactating & pregnant women
auto-immune hepatitis
Hepatitis B,C,D
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To get the billirubin quantity to normal levels and to cure the echogenesity of liver parenchymal cellsTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method To reduce the elevated liver enzymes and viral loadTimepoint: 3 months